73 Appendix 3, Regulation (EU) 2019/1390

In forcesince 31 Jul 2019
1.

Test species

Xenopus laevis

2.

Test type

Continuous flow-through,

3.

Water temperature

The nominal temperature is 21 oC. The mean temperature over the duration of the test is 21 ± 1 oC (the inter-replicate and the inter-treatment differentials should not exceed 1,0 oC)

4.

Illumination quality

Fluorescent bulbs (wide spectrum) 600-2000 lux (lumens/m2) at the water surface

5.

Photoperiod

12 h light:12 h dark

6.

Test solution volume and test vessel (tank)

4-10 l (minimum 10–15 cm water depth)

Glass or stainless steel tank

7.

Volume exchanges of test solutions

Constant, in consideration of both the maintenance of biological conditions and chemical exposure (e.g., 5 tank volume renewal per day)

8.

Age of test organisms at initiation

Nieuwkoop and Faber (NF) stage 8-10

9.

Number. of organisms per replicate

20 animals (embryos)/tank (replicate) at exposure initiation and 10 animals (juveniles)/tank (replicate) after NF stage 66 to exposure termination

10.

Number of treatments

Minimum 4 test chemical treatments plus appropriate control(s)

11.

Number of replicates per treatment

4 replicates per treatment for test chemical and 8 replicates for control(s)

12.

Number of organisms per test concentration

Minimum 80 animals per treatment for test chemical and minimum 160 animals for control(s)

13.

Dilution water

Any water that permits normal growth and development of X. laevis (e.g., spring water or charcoal-filtered tap water)

14.

Aeration

None required, but aeration of the tanks may be necessary if dissolved oxygen levels drop below recommended limits and increases in flow of test solution is maximised.

15.

Dissolved oxygen of test solution

Dissolved oxygen: ≥ 40 % of air saturation value or ≥ 3,5 mg/l

16.

pH of test solution

6.5-8.5 (the inter-replicate and the inter-treatment differentials should not exceed 0,5)

17.

Hardness and alkalinity of test solution

10-250 mg CaCO3/l

18.

Feeding regime

(See Appendix 4)

19.

Exposure period

From NF stage 8-10 to ten weeks after the median time to NF stage 62 in water and/or solvent control group (maximum 17 weeks)

20.

Biological endpoints

Mortality (and abnormal appearances), time to NF stage 62 (larval sample), thyroid histology assessment (larval sample), growth (weight and length), liver-somatic index (juvenile sample), genetic/phenotypic sex ratios (juvenile sample), histopathology for gonads, reproductive ducts, kidney and liver (juvenile sample) and plasma vitellogenin (juvenile sample, optional)

21.

Test validity criteria

Dissolved oxygen should be > 40 % air saturation value; mean water temperature should be 21 ± 1 oC and the inter-replicate and -treatment differentials should be < 1.0 oC; pH of test solution should be ranged between 6,5 and 8.5; the mortality in control should be ≤ 20 % in each replicate, and the mean time to NF stage 62 in control should be ≤ 45 days; the mean weight of test organisms at NF stage 62 and at the termination of the assay in controls and solvent controls (if used) should reach 1,0 ± 0,2 and 11,5 ± 3 g, respectively; evidence should be available to demonstrate that the concentrations of the test chemical in solution have been satisfactorily maintained within ± 20 % of the mean measured values.